All Q2 FY27 results →
BA

Balaji Amines Ltd

Q2 FY27Chemicals & Petrochemicals

Balaji Amines Q2 Results 2026 (FY27) statement: Revenue & Margins

Q2 FY27 results statement: what the company reported on revenue, margins and capex.

Price₹1,811
Market cap₹5.9K Cr
P/E28.8
Updated2 Nov 2026
Read1 min read

Based on Balaji Amines Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

The short version

EBITDA for the quarter: Rs.

From Balaji Amines Ltd's Q2 FY27 earnings-call transcript · updated 2 Nov 2026.

Revenue & Sales Performance

  • The financial information provided focuses on unaudited standalone and consolidated financial results, audit reviews, cash flows, and statements of assets and liabilities.
  • Notes mention that the financial results are prepared as per Indian Accounting Standards (Ind AS), including segment information per Ind AS-108, but detailed sales or volume data or outlook is absent.

Profitability & Margins

See what Balaji Amines Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what Balaji Amines Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Balaji Amines Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Balaji Amines Ltd said on order book & pipeline — free account, 30 seconds.

Balaji Amines Ltd — Quarterly revenue & net profit

Revenue Net profit
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹456 Cr, net profit ₹78 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Sh.Pushkar Chem. (Q2 FY27)

    Revenue from operations for the quarter ended September 30, 2026, was ₹22,954.33 lakhs. Key results statement takeaways from Shree Pushkar Chemicals & Fertilize

  • Vital Chemtech (Q2 FY27)

    EBITDA for the quarter ended September 30, 2026:** ₹78.82 Lakhs . Key results statement takeaways from Vital Chemtech Ltd's Q2 FY27 results statement — and how

  • Fine Organic (Q2 FY27)

    For the quarter ended September 30, 2026, Fine Organic Industries Limited reported revenue from operations of INR 729.39 crores. Key results statement takeaways

  • Primo Chemicals (Q2 FY27)

    Quarterly EBITDA**: ₹1,752 mn, up 9% YoY (from ₹1,608 mn) . Key results statement takeaways from Primo Chemicals Ltd's Q2 FY27 results statement — and how it ra

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Balaji Amines Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Balaji Amines Ltd Q2 FY27 results?

EBITDA for the quarter: Rs.

What is Balaji Amines Ltd share price analysis?

Balaji Amines Ltd currently shows a neutral. The stock trades at a P/E of 28.8 with a market cap of ₹5,868 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Balaji Amines Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.